Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Hatzl Stefan |

** = Publikationen gelistet in SCI/SSCI/Pubmed

2025

Originalarbeit (Zeitschrift)

** Eichinger, M; Zoidl, P; Reisinger, AC; Orlob, S; Hatzl, S; Eichlseder, M; Pichler, A; Eberl, A; Kuenzer, T; Zajic, P; Heuschneider, L; Honnef, G; Rief, M; Bornemann-Cimenti, H Assessment of frontal EEG measurement in out-of-hospital cardiac arrest: a prospective observational feasibility study - study protocol.
BMJ Open. 2025; 15(2): e094258 Doi: 10.1136/bmjopen-2024-094258 [OPEN ACCESS]
PubMed PUBMED Central FullText FullText_MUG

 

** Hatzl, S; Geiger, C; Kriegl, L; Reinisch, A; Wölfler, A; Apfaltrer, G; Keldorfer, M; Rödl, S; Hoenigl, M; Eller, P; Krause, R Pulmonary Coinfection of Pneumocystis jirovecii and Aspergillus Species.
Open Forum Infect Dis. 2025; 12(2): ofaf018 Doi: 10.1093/ofid/ofaf018 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Hatzl, S; Kriegl, L; Geiger, C; Eller, P; Krause, R Lateral Flow Device Aspergillus Routine Testing for Invasive Pulmonary Aspergillosis in Patients Who Are Critically Ill: A Multicenter Intensive Care Unit Cohort Study.
Open Forum Infect Dis. 2025; 12(5): ofaf256 Doi: 10.1093/ofid/ofaf256 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Prattes, J; Giacobbe, DR; Marelli, C; Signori, A; Dettori, S; Cattardico, G; Hatzl, S; Reisinger, AC; Eller, P; Krause, R; Reizine, F; Bassetti, M; Gangneux, JP; Hoenigl, M Posaconazole for Prevention of COVID-19-Associated Pulmonary Aspergillosis in Mechanically Ventilated Patients: A European Multicentre Case-Control Study (POSACOVID).
Mycoses. 2025; 68(1): e70023 Doi: 10.1111/myc.70023 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Reisinger, AC; Schneider, N; Koellinger, M; Hatzl, S; Hackl, G; Raggam, R; von, Lewinski, D; Posch, F; Eller, P Anticoagulation Monitoring Strategies During Extracorporeal Membrane Oxygenation (ECMO) Therapy - Differences Between Simultaneously Obtained Coagulation Tests: A Retrospective Single-Center Cohort Study.
J Intensive Care Med. 2025; 8850666241313357 Doi: 10.1177/08850666241313357
Web of Science PubMed FullText FullText_MUG

 

Kurzbericht/Letter

** Hatzl, S; Kriegl, L; Geiger, C; Eller, P; Krause, R Validation of the "invasive pulmonary aspergillosis in immunocompromised patients with acute respiratory failure score" (IPA-GRRR-OH score).
Intensive Care Med. 2025; 51(4):831-832 Doi: 10.1007/s00134-025-07838-9
Web of Science PubMed FullText FullText_MUG

 

Übersichtsarbeit

** Hatzl, S; Posch, F; Scholz, L; Geiger, C; Kriegl, L; Kreuzer, P; Eller, P; Giacobbe, DR; Bassetti, M; Hoenigl, M; Krause, R Comparative efficacy and safety of treatment regimens for Pneumocystis jirovecii pneumonia in people living with HIV: a systematic review and network meta-analysis of randomized controlled trials.
Clin Microbiol Infect. 2024; Doi: 10.1016/j.cmi.2024.12.024
Web of Science PubMed FullText FullText_MUG

 

Kommentar

** Kreuzer, P; Hatzl, S Comment on: Prehospital interventions and outcomes in traumatic cardiac arrest: a population-based cohort study using Danish helicopter emergency medical services data.
Eur J Emerg Med. 2025; 32(2): 149 Doi: 10.1097/MEJ.0000000000001191
Web of Science PubMed FullText FullText_MUG

 

2024

Originalarbeit (Zeitschrift)

** Hatzl, S; Geiger, C; Kriegl, L; Scholz, L; Reisinger, AC; Kreuzer, P; Fruhwald, S; Wölfler, A; Reinisch, A; von, Lewinski, D; Schilcher, G; Hoenigl, M; Eller, P; Krause, R Performance of diagnostic algorithms in patients with invasive pulmonary aspergillosis.
Clin Infect Dis. 2024; Doi: 10.1093/cid/ciae633
Web of Science PubMed FullText FullText_MUG

 

** Hatzl, S; Scholz, L; Posch, F; Eller, P; Reisinger, AC; Zacharias, M; Gorkiewicz, G; Hoenigl, M; Zollner-Schwetz, I; Krause, R Invasive Pulmonary Aspergillosis in Critically Ill Patients with Hantavirus Infection, Austria.
Emerg Infect Dis. 2024; 30(6): 1275-1278. Doi: 10.3201/eid3006.231720 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Reisinger, AC; Hatzl, S; Prattes, J; Hackl, G; Schilcher, G; Eisner, F; Niedrist, T; Raggam, R; Krause, R; Eller, P Soluble urokinase plasminogen activator receptor (suPAR) in bronchoalveolar fluid and blood in critically ill patients-a prospective cohort study.
Infection. 2024; 52(1):249-252 Doi: 10.1007/s15010-023-02127-3 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Scholz, L; Posch, F; Schulz, E; Gornicec, M; Wölfler, A; Reisinger, AC; Reinisch, A; Eller, P; Eisner, F; Kreuzer, P; Stradner, M; Rosenkranz, AR; Krammer, F; Schilcher, G; Krause, R; Hatzl, S Ruxolitinib, IV Immunoglobulin, and High-Dose Glucocorticoids for Critically Ill Adults With Secondary Hemophagocytic Lymphohistiocytosis: A Single-Center Observational Pilot Study.
Crit Care Explor. 2024; 6(2): e1046 Doi: 10.1097/CCE.0000000000001046 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Skok, K; Zacharias, M; Verheyen, N; Hatzl, S; Scholz, L; Langner, C; Hoefler, G; Vagena, FR Myeloid sarcoma of the heart-A clinicopathological correlation.
Wien Klin Wochenschr. 2024; Doi: 10.1007/s00508-024-02478-3 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Übersichtsarbeit

** Kriegl, L; Hatzl, S; Schilcher, G; Zollner-Schwetz, I; Boyer, J; Geiger, C; Hoenigl, M; Krause, R Antifungals in Patients With Extracorporeal Membrane Oxygenation: Clinical Implications.
Open Forum Infect Dis. 2024; 11(6): ofae270 Doi: 10.1093/ofid/ofae270 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Puseljic, M; Schmid, J; Igrec, J; Hatzl, S; Scholz, L; Woelfler, A; Fuchsjäger, M; Talakic, E Pulmonary manifestations of VEXAS syndrome with acute interstitial pneumonia and diffuse alveolar hemorrhage: a case report and literature review
ARP RHEUMATOL. 2024; 3(2): 151-156. Doi: 10.63032/EVGB1553 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Scholz, L; Stelzl, A; Schlager, H; Konrad, J; Blesl, A; Hauser, A; Reisinger, A; Eller, P; Hatzl, S; Kolland, M; Baumann-Durchschein, F Spontaneous mucosal tear in lymphocytic esophagitis-A case report
MED KLIN-INTENSIVMED. 2024; 119(5): 441-441. [Poster]
Web of Science

 

2023

Originalarbeit (Zeitschrift)

** Hatzl, S; Kriegl, L; Posch, F; Schilcher, G; Eller, P; Reisinger, A; Grinschgl, Y; Muhr, T; Meinitzer, A; Hoenigl, M; Krause, R Early attainment of isavuconazole target concentration using an increased loading dose in critically ill patients with extracorporeal membrane oxygenation.
J Antimicrob Chemother. 2023; 78(12):2902-2908 Doi: 10.1093/jac/dkad328
Web of Science PubMed FullText FullText_MUG

 

** Hodl, I; Sallegger, C; Forstner, P; Sareban, N; Moritz, M; Dreo, B; Schulz, E; Lackner, A; Kleinhappl, B; Hatzl, S; Moazedi-Fürst, F; Seifert-Held, T; Heschl, B; Khalil, M; Enzinger, C; Greinix, H; Stradner, MH; Steinmetz, I; Schlenke, P; Fessler, J Altered cellular immune response to vaccination against SARS-CoV-2 in patients suffering from autoimmunity with B-cell depleting therapy.
Microbes Infect. 2023; 25(4):105103 Doi: 10.1016/j.micinf.2023.105103 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Schreiber, N; Reisinger, AC; Hatzl, S; Schneider, N; Scholz, L; Herrmann, M; Kolland, M; Schuller, M; Kirsch, AH; Eller, K; Kink, C; Fandler-Höfler, S; Rosenkranz, AR; Hackl, G; Eller, P Biomarkers of alcohol abuse potentially predict delirium, delirium duration and mortality in critically ill patients.
iScience. 2023; 26(10): 108044 Doi: 10.1016/j.isci.2023.108044 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Kurzbericht/Letter

** Hatzl, S; Posch, F; Linhofer, M; Aberle, S; Zollner-Schwetz, I; Krammer, F; Krause, R Poor Prognosis for Puumala Virus Infections Predicted by Lymphopenia and Dyspnea.
Emerg Infect Dis. 2023; 29(5): 1038-1041. Doi: 10.3201/eid2905.221625 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Seles, M; Altziebler, J; Gorkiewicz, G; Kriegl, L; Hatzl, S; Ahyai, S; Klasinc, R; Zollner-Schwetz, I; Krause, R Human Tularemia Epididymo-Orchitis Caused by Francisella tularensis Subspecies holartica, Austria.
Emerg Infect Dis. 2023; 29(10): 2105-2107. Doi: 10.3201/eid2910.230436 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Korrektur

** Meert, AP; Toffart, AC; Picard, M; Jaubert, P; Gibelin, A; Bauer, P; Mokart, D; Van, De, Louw, A; Hatzl, S; Moreno-Gonzales, G; Rousseau-Bussac, G; Bruneel, F; Montini, L; Moreau, AS; Carpentier, D; Seguin, A; Hemelaar, P; Azoulay, E; Lemiale, V Erratum to "When targeted therapy for cancer leads to ICU admission. RETRO-TARGETICU multicentric study" [Bull. Cancer 109 (2022) 916-24].
Bull Cancer. 2023; 110(4):467-468 Doi: 10.1016/j.bulcan.2023.02.001
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Scholz, L; Posch, F; Schulz, E; Gornicec, M; Rosenkranz, AR; Schilcher, G; Reisinger, A; Krause, R; Hatzl, S Ruxolitinib, intravenous immunoglobulin and high-dose corticosteroids in the management of critically ill adult patients with hemophagocytic lymphohistiocytosis
MED KLIN-INTENSIVMED. 2023; 118(5): [Oral Communication]
Web of Science

 

** Schulz, E; Grumaz, S; Hatzl, S; Gornicec, M; Valentin, T; Huber-Krassnitzer, B; Kriegl, L; Uhl, B; Deutsch, A; Greinix, H; Krause, R; Neumeister, P Pathogen detection by metagenomic next-generation sequencing during neutropenic fever in patients with haematological malignancies
BRIT J HAEMATOL. 2023; 201: 21-22.-63rd Annual Scientific Meeting of the British-Society-for-Haematology; APR 23-25, 2023; Birmingham, ENGLAND. [Poster]
Web of Science

 

2022

Originalarbeit (Zeitschrift)

** Kriegl, L; Hatzl, S; Zurl, C; Reisinger, AC; Schilcher, G; Eller, P; Gringschl, Y; Muhr, T; Meinitzer, A; Prattes, J; Hoenigl, M; Krause, R Isavuconazole plasma concentrations in critically ill patients during extracorporeal membrane oxygenation.
J Antimicrob Chemother. 2022; 77(9):2500-2505 Doi: 10.1093/jac/dkac196 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Meert, AP; Toffart, AC; Picard, M; Jaubert, P; Gibelin, A; Bauer, P; Mokart, D; Van, De, Louw, A; Hatzl, S; Moreno-Gonzales, G; Rousseau-Bussac, G; Bruneel, F; Montini, L; Moreau, AS; Carpentier, D; Seguin, A; Hemelaar, P; Azoulay, E; Lemiale, V When targeted therapy for cancer leads to ICU admission. RETRO-TARGETICU multicentric study.
Bull Cancer. 2022; 109(9):916-924 Doi: 10.1016/j.bulcan.2022.04.014
Web of Science PubMed FullText FullText_MUG

 

** Prattes, J; Wauters, J; Giacobbe, DR; Salmanton-García, J; Maertens, J; Bourgeois, M; Reynders, M; Rutsaert, L; Van, Regenmortel, N; Lormans, P; Feys, S; Reisinger, AC; Cornely, OA; Lahmer, T; Valerio, M; Delhaes, L; Jabeen, K; Steinmann, J; Chamula, M; Bassetti, M; Hatzl, S; Rautemaa-Richardson, R; Koehler, P; Lagrou, K; Hoenigl, M, , ECMM-CAPA, Study, Group Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a multinational observational study by the European Confederation of Medical Mycology.
Clin Microbiol Infect. 2022; 28(4):580-587 Doi: 10.1016/j.cmi.2021.08.014 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Riedl, JM; Schwarzenbacher, E; Moik, F; Horvath, L; Gantschnigg, A; Renneberg, F; Posch, F; Barth, DA; Stotz, M; Pichler, M; Hatzl, S; Fandler-Höfler, S; Gressenberger, P; Gary, T; Jost, PJ; Greil, R; Ay, C; Djanani, A; Gerger, A; Schlick, K Patterns of Thromboembolism in Patients with Advanced Pancreatic Cancer Undergoing First-Line Chemotherapy with FOLFIRINOX or Gemcitabine/nab-Paclitaxel.
Thromb Haemost. 2022; 122(4):633-645 Doi: 10.1055/a-1548-4847
Web of Science PubMed FullText FullText_MUG

 

** Schulz, E; Grumaz, S; Hatzl, S; Gornicec, M; Valentin, T; Huber-Kraßnitzer, B; Kriegl, L; Uhl, B; Deutsch, A; Greinix, H; Krause, R; Neumeister, P Pathogen Detection by Metagenomic Next-Generation Sequencing During Neutropenic Fever in Patients With Hematological Malignancies.
Open Forum Infect Dis. 2022; 9(8): ofac393 Doi: 10.1093/ofid/ofac393 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Kurzbericht/Letter

** Schreiber, N; Manninger, M; Pätzold, S; Reisinger, AC; Hatzl, S; Hackl, G; Högenauer, C; Eller, P Cardiogenic shock due to yew poisoning rescued by VA-ECMO: case report and literature review.
Channels (Austin). 2022; 16(1): 167-172. Doi: 10.1080/19336950.2022.2104886 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Übersichtsarbeit

** Reider, S; Binder, L; Fürst, S; Hatzl, S; Blesl, A Hematopoietic Stem Cell Transplantation in Refractory Crohn's Disease: Should It Be Considered?
Cells. 2022; 11(21): Doi: 10.3390/cells11213463 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Kommentar

** Hatzl, S; Krause, R; Schilcher, G Early Treatment with Sotrovimab for Covid-19.
N Engl J Med. 2022; 386(15): 1480 Doi: 10.1056/NEJMc2201606
Web of Science PubMed FullText FullText_MUG

 

** Hatzl, S; Schilcher, G; Hoenigl, M; Kriegl, L; Krause, R Isavuconazole plasma concentrations in critically ill patients during extracorporeal membrane oxygenation-authors' response.
J Antimicrob Chemother. 2022; 77(12):3528-3529 Doi: 10.1093/jac/dkac357
Web of Science PubMed FullText FullText_MUG

 

2021

Originalarbeit (Zeitschrift)

** Berg, JL; Perfler, B; Hatzl, S; Mayer, MC; Wurm, S; Uhl, B; Reinisch, A; Klymiuk, I; Tierling, S; Pregartner, G; Bachmaier, G; Berghold, A; Geissler, K; Pichler, M; Hoefler, G; Strobl, H; Wölfler, A; Sill, H; Zebisch, A Micro-RNA-125a mediates the effects of hypomethylating agents in chronic myelomonocytic leukemia.
Clin Epigenetics. 2021; 13(1): 1-1. Doi: 10.1186/s13148-020-00979-2 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Berg, JL; Perfler, B; Hatzl, S; Uhl, B; Reinisch, A; Pregartner, G; Berghold, A; Penz, T; Schuster, M; Geissler, K; Prokesch, A; Müller-Tidow, C; Hoefler, G; Kashofer, K; Wölfler, A; Sill, H; Caraffini, V; Zebisch, A EZH2 inactivation in RAS-driven myeloid neoplasms hyperactivates RAS-signaling and increases MEK inhibitor sensitivity.
Leukemia. 2021; 35(5):1521-1526 Doi: 10.1038/s41375-021-01161-0 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Hatzl, S; Kalmar, P; Posch, F; Riedl, JM; Beham-Schmid, C; Prochazka, K; Greinix, H; Schwarz, T; Gstettner, C; Neumeister, P; Schulz, E Prognostic Value of Baseline and Interim Positron Emission Tomography Markers in Diffuse Large B-cell Lymphoma Patients: A Real-world Perspective.
Hemasphere. 2021; 5(8): e621 Doi: 10.1097/HS9.0000000000000621 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Hatzl, S; Posch, F; Rezai, A; Gornicec, M; Beham-Schmid, C; Magnes, T; Wangner, S; Deutsch, A; Greinix, H; Uhl, B; Prochazka, KT; Egle, A; Greil, R; Melchardt, T; Linkesch, W; Schulz, E; Neumeister, P Vinorelbine as substitute for vincristine in patients with diffuse large B cell lymphoma and vincristine-induced neuropathy.
Support Care Cancer. 2021; 29(9):5197-5207 Doi: 10.1007/s00520-021-06059-2 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Hatzl, S; Posch, F; Sareban, N; Stradner, M; Rosskopf, K; Reisinger, AC; Eller, P; Schörghuber, M; Toller, W; Sloup, Z; Prüller, F; Gütl, K; Pilz, S; Rosenkranz, AR; Greinix, HT; Krause, R; Schlenke, P; Schilcher, G Convalescent plasma therapy and mortality in COVID-19 patients admitted to the ICU: a prospective observational study.
Ann Intensive Care. 2021; 11(1): 73 Doi: 10.1186/s13613-021-00867-9 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Hatzl, S; Reisinger, AC; Posch, F; Prattes, J; Stradner, M; Pilz, S; Eller, P; Schoerghuber, M; Toller, W; Gorkiewicz, G; Metnitz, P; Rief, M; Prüller, F; Rosenkranz, AR; Valentin, T; Krause, R; Hoenigl, M; Schilcher, G Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study.
Crit Care. 2021; 25(1): 335 Doi: 10.1186/s13054-021-03753-9 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Reisinger, AC; Niedrist, T; Posch, F; Hatzl, S; Hackl, G; Prattes, J; Schilcher, G; Meißl, AM; Raggam, RB; Herrmann, M; Eller, P Soluble urokinase plasminogen activator receptor (suPAR) predicts critical illness and kidney failure in patients admitted to the intensive care unit.
Sci Rep. 2021; 11(1): 17476 Doi: 10.1038/s41598-021-96352-1 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Schulz, E; Hodl, I; Forstner, P; Hatzl, S; Sareban, N; Moritz, M; Fessler, J; Dreo, B; Uhl, B; Url, C; Grisold, AJ; Khalil, M; Kleinhappl, B; Enzinger, C; Stradner, MH; Greinix, HT; Schlenke, P; Steinmetz, I CD19+IgD+CD27- Naïve B Cells as Predictors of Humoral Response to COVID 19 mRNA Vaccination in Immunocompromised Patients.
Front Immunol. 2021; 12:803742 Doi: 10.3389/fimmu.2021.803742 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Spindelboeck, W; Halwachs, B; Bayer, N; Huber-Krassnitzer, B; Schulz, E; Uhl, B; Gaksch, L; Hatzl, S; Bachmayr, V; Kleissl, L; Kump, P; Deutsch, A; Stary, G; Greinix, H; Gorkiewicz, G; Högenauer, C; Neumeister, P Antibiotic use and ileocolonic immune cells in patients receiving fecal microbiota transplantation for refractory intestinal GvHD: a prospective cohort study.
Ther Adv Hematol. 2021; 12:20406207211058333 Doi: 10.1177/20406207211058333 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Kurzbericht/Letter

** Mayer, MC; Berg, JL; Perfler, B; Hatzl, S; Herzog, SA; Bachmaier, G; Berghold, A; Reinisch, A; Wölfler, A; Sill, H; Zebisch, A miR-23a mediates resistance to hypomethylating agents in myeloid neoplasms.
ANN HEMATOL. 2021; 100(11): 2845-2847. Doi: 10.1007/s00277-021-04598-6
Web of Science PubMed FullText FullText_MUG

 

** Prattes, J; Wauters, J; Giacobbe, DR; Lagrou, K; Hoenigl, M, , ECMM-CAPA, Study, Group Diagnosis and treatment of COVID-19 associated pulmonary apergillosis in critically ill patients: results from a European confederation of medical mycology registry.
Intensive Care Med. 2021; 47(10):1158-1160 Doi: 10.1007/s00134-021-06471-6 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Fallbericht

** Zurl, C; Hoenigl, M; Schulz, E; Hatzl, S; Gorkiewicz, G; Krause, R; Eller, P; Prattes, J Autopsy Proven Pulmonary Mucormycosis Due to Rhizopus microsporus in a Critically Ill COVID-19 Patient with Underlying Hematological Malignancy.
J Fungi (Basel). 2021; 7(2): Doi: 10.3390/jof7020088 (- Case Report) [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2020

Originalarbeit (Zeitschrift)

** Caraffini, V; Geiger, O; Rosenberger, A; Hatzl, S; Perfler, B; Berg, JL; Lim, C; Strobl, H; Kashofer, K; Schauer, S; Beham-Schmid, C; Hoefler, G; Geissler, K; Quehenberger, F; Kolch, W; Athineos, D; Blyth, K; Wölfler, A; Sill, H; Zebisch, A Loss of RAF kinase inhibitor protein is involved in myelomonocytic differentiation and aggravates RAS-driven myeloid leukemogenesis.
Haematologica. 2020; 105(2):375-386 Doi: 10.3324/haematol.2018.209650 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Hatzl, S; Perfler, B; Wurm, S; Uhl, B; Quehenberger, F; Ebner, S; Troppmair, J; Reinisch, A; Wölfler, A; Sill, H; Zebisch, A Increased Expression of Micro-RNA-23a Mediates Chemoresistance to Cytarabine in Acute Myeloid Leukemia.
Cancers (Basel). 2020; 12(2): Doi: 10.3390/cancers12020496 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Hatzl, S; Posch, F; Deutsch, A; Beham-Schmid, C; Stöger, H; Greinix, H; Pichler, M; Neumeister, P; Prochazka, KT Immunohistochemistry for c-myc and bcl-2 overexpression improves risk stratification in primary central nervous system lymphoma.
Hematol Oncol. 2020; 38(3):277-283 Doi: 10.1002/hon.2727 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Kurzbericht/Letter

** Hatzl, S; Posch, F; Schulz, E; Gornicec, M; Deutsch, A; Beham-Schmid, C; Pichler, M; Greinix, H; Sill, H; Zebisch, A; Neumeister, P; Prochazka, KT The Role of Immunohistochemical Overexpression of p53 as Adverse Prognostic Factor in Primary Testicular Diffuse Large B Cell Lymphoma.
Pathol Oncol Res. 2020; 26(4):2831-2833 Doi: 10.1007/s12253-020-00864-6
Web of Science PubMed FullText FullText_MUG

 

** Zebisch, A; Winter, G; Kashofer, K; Hatzl, S; Uhl, B; Wurm, S; Wölfler, A; Greinix, HT; Hoefler, G; Sill, H The role of germline mutation profiling in the selection of related donors for haematopoietic stem cell transplantation.
Bone Marrow Transplant. 2020; 55(7):1502-1505 Doi: 10.1038/s41409-019-0691-1 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Kommentar

** Hatzl, S; Eisner, F; Schilcher, G; Kreuzer, P; Gornicec, M; Eller, P; Brodmann, M; Schlenke, P; Stradner, MH; Krause, R; Greinix, H; Schulz, E Response to "COVID-19 in persons with haematological cancers".
Leukemia. 2020; 34(8):2265-2270 Doi: 10.1038/s41375-020-0914-x [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Posch, F; Hatzl, S; Ay, C Heparins as cancer therapy: in theory, they should have worked.
Lancet Haematol. 2020; 7(10): e703-e704-e703-e704. Doi: 10.1016/S2352-3026(20)30276-3
Web of Science PubMed FullText FullText_MUG

 

2019

Fallbericht

** Hatzl, S; Greinix, HT; Kreuzer, P; Schulz, E; Neumeister, P; Scherr, D A wearable cardioverter defibrillator for prevention of sudden cardiac death in a hematologic patient-a case report
MEMO-MAG EUR MED ONC. 2019; 12(3): 269-271. Doi: 10.1007/s12254-019-0514-5 [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

Abstract (Zeitschrift)

** Uhl, B; Prochazka, K; Wenzl, K; Hatzl, S; Greinix, HT; Beham-Schmid, C; Neumeister, P; Deutsch, A Differences of the chemokine receptor expression profile of aggressive lymphoma and GCB-cells and probable influence on clinical outcome
ONCOL RES TREAT. 2019; 42: 83-83. [Poster]
Web of Science

 

2018

Originalarbeit (Zeitschrift)

** Hatzl, S; Uhl, B; Hinterramskogler, M; Leber, S; Eisner, F; Haring, M; Jud, P Acute myeloid leukemia with severe coagulation disorder and concomitant central nervous system bleeding - a clinical diagnostic case report.
EJIFCC. 2018; 29(2): 146-151. (- Case Report) [OPEN ACCESS]
PubMed PUBMED Central

 

Fallbericht

** Hatzl, S; Kreuzer, P; Jud, P; Tension Hydropneumothorax after Lung Biopsy.
NOTFALL RETTUNGSMED. 2018; 21(8): 695-696. Doi: 10.1007/s10049-018-0461-4 [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

Abstract (Zeitschrift)

** Caraffini, V; Geiger, O; Rosenberger, A; Hatzl, S; Perfler, B; Berg, JL; Lim, C; Strobl, H; Kashofer, K; Hoefler, G; Geissler, K; Kolch, W; Blyth, K; Athineos, D; Wolfler, A; Sill, H; Zebisch, A Loss of RKIP expression is a frequent event in chronic myelomonocytic leukemia and functionally involved in the pathogenesis of this malignancy
ONCOL RES TREAT. 2018; 41: 27-27. [Oral Communication]
Web of Science

 

** Hatzl, S; Ebner, S; Perfler, B; Quehenberger, F; Troppmair, J; Reinisch, A; Wolfler, A; Sill, H; Zebisch, A Deregulation of the micro-RNA-23a/TOP2B axis causes resistance to cytarabine in acute myeloid leukemia
ONCOL RES TREAT. 2018; 41: 243-243. [Oral Communication]
Web of Science

 

2017

Originalarbeit (Zeitschrift)

** Deutsch, AJA; Rinner, B; Pichler, M; Prochazka, K; Pansy, K; Bischof, M; Fechter, K; Hatzl, S; Feichtinger, J; Wenzl, K; Frisch, MT; Stiegelbauer, V; Prokesch, A; Krogsdam, A; Sill, H; Thallinger, GG; Greinix, HT; Wang, C; Beham-Schmid, C; Neumeister, P NR4A3 Suppresses Lymphomagenesis through Induction of Proapoptotic Genes.
Cancer Res. 2017; 77(9):2375-2386 Doi: 10.1158/0008-5472.CAN-16-2320 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Caraffini, V; Geiger, O; Rosenberger, A; Hatzl, S; Perfler, B; Berg, JL; Lim, C; Strobl, H; Kashofer, K; Hoefler, G; Geissler, K; Kolch, W; Blyth, K; Athineos, D; Woelfler, A; Sill, H; Zebisch, A LOSS OF RAF KINASE INHIBITOR PROTEIN IS INVOLVED IN MYELOMONOCYTIC LINEAGE COMMITMENT AND AGGRAVATES THE DEVELOPMENT OF CHRONIC MYELOMONOCYTIC LEUKEMIA IN A MURINE IN-VIVO MODEL
HAEMATOLOGICA. 2017; 102: 148-149.-22nd Congress of the European-Hematology-Association; JUN 22-25, 2017; Madrid, SPAIN. [Oral Communication]
Web of Science

 

2016

Originalarbeit (Zeitschrift)

** Hatzl, S; Geiger, O; Kuepper, MK; Caraffini, V; Seime, T; Furlan, T; Nussbaumer, E; Wieser, R; Pichler, M; Scheideler, M; Nowek, K; Jongen-Lavrencic, M; Quehenberger, F; Wölfler, A; Troppmair, J; Sill, H; Zebisch, A Increased Expression of miR-23a Mediates a Loss of Expression in the RAF Kinase Inhibitor Protein RKIP.
Cancer Res. 2016; 76(12):3644-3654 Doi: 10.1158/0008-5472.CAN-15-3049 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Simone, G; De Nunzio, C; Ferriero, M; Cindolo, L; Brookman-May, S; Papalia, R; Sperduti, I; Collura, D; Leonardo, C; Anceschi, U; Tuderti, G; Misuraca, L; Dalpiaz, O; Hatzl, S; Lodde, M; Trenti, E; Pastore, AL; Palleschi, G; Lotrecchiano, G; Salzano, L; Carbone, A; De Cobelli, O; Tubaro, A; Schips, L; Zigeuner, R; Tostain, J; May, M; Guaglianone, S; Muto, G; Gallucci, M Trends in the use of partial nephrectomy for cT1 renal tumors: Analysis of a 10-yr European multicenter dataset.
Eur J Surg Oncol. 2016; 42(11):1729-1735 Doi: 10.1016/j.ejso.2016.03.022
Web of Science PubMed FullText FullText_MUG

 

Übersichtsarbeit

** Zebisch, A; Hatzl, S; Pichler, M; Wölfler, A; Sill, H Therapeutic Resistance in Acute Myeloid Leukemia: The Role of Non-Coding RNAs.
Int J Mol Sci. 2016; 17(12): Doi: 10.3390/ijms17122080 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2015

Originalarbeit (Zeitschrift)

** Milewska, M; Romano, D; Herrero, A; Guerriero, ML; Birtwistle, M; Quehenberger, F; Hatzl, S; Kholodenko, BN; Segatto, O; Kolch, W; Zebisch, A Mitogen-Inducible Gene-6 Mediates Feedback Inhibition from Mutated BRAF towards the Epidermal Growth Factor Receptor and Thereby Limits Malignant Transformation.
PLoS One. 2015; 10(6):e0129859-e0129859 Doi: 10.1371/journal.pone.0129859 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Kurzbericht/Letter

** Geiger, O; Hatzl, S; Kashofer, K; Hoefler, G; Wölfler, A; Sill, H; Zebisch, A Deletion of SPRY4 is a frequent event in secondary acute myeloid leukemia.
Ann Hematol. 2015; 94(11):1923-1924 Doi: 10.1007/s00277-015-2445-5 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Abstract (Zeitschrift)

** Hatzl, S; Geiger, O; Kuepper, MK; Seime, T; Nussbaumer, E; Wieser, R; Pichler, M; Scheideler, M; Nowek, K; Jongen-Lavrencic, M; Wolfler, A; Troppmair, J; Sill, H; Zebisch, A Loss of the tumor- and metastasis suppressor RAF kinase inhibitor protein is caused by the overexpression of miRNA-23a
ONCOL RES TREAT. 2015; 38: 99-99. [Oral Communication]
Web of Science

 

2014

Abstract (Zeitschrift)

** Zebisch, A; Wolf, O; Rosenberger, A; Petricevic, P; Hatzl, S; Troppmair, J; Kolch, W; Blyth, K; Haller, M; Sill, H; Woelfler, A RAF kinase inhibitor protein is involved in the regulation of myelomonocytic differentiation.
Oncol Res Treat. 2014; 37(S5):49-49. 2014; 37(S5):24-24.-Annual Meeting of the German, Austrian and Swiss Associations of Hematology and Medical Oncology; OCT 10-14; Hamburg. (ISBN: 978-3-318-0281 ) [Oral Communication]
Web of Science

 

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum